SENSOPAD - Sensing Endometriosis On Portable Auxiliary Devices

The SENSOPAD project represents a groundbreaking leap in addressing the challenges posed by endometriosis. The visionary approach of SENSOPAD involves empowering individuals through SENSOPAD's sophisticated sensors designed for self-monitoring. These devices employ cutting-edge technology to efficiently detect relevant biomarkers, providing users with valuable insights during their menstrual cycles. If initial readings indicate potential concerns, a seamless transition occurs, guiding users to employ the SENSOPAD Microfluidic graphene transistor device at clinical entry points. The integration of the pad and the transistor with a mobile application and a cloud platform enhances diagnostic accuracy significantly. This initiative not only enables early treatment, preventing the deterioration of debilitating symptoms and optimizing infertility care but also significantly enhances patients' quality of life. SENSOPAD offers a simple, autonomous, and non-invasive form of screening, eliminating the need for expensive and time-consuming in-lab diagnosis. In essence, SENSOPAD represents a paradigm shift, forging a path towards more informed, proactive, and inclusive healthcare decisions for women worldwide.

• Employees 0